Anyone on GLP-1's for multiple years?

ChemBB

Member
I was RX'ed Mounjaro 2 years ago, and have been using various GLP-1's ever since.

tl;dr, at least in terms of appetite, they are doing fuckall for me now
I'm up to 10mg Reta + 3mg Sema and still so hungry, not losing weight anymore.

At this point I'm considering just pinning a vial of Reta E3D, may as well be sugar water...

Anyone else dealt with/overcome this?
 
That is, those of us who can tolerate grams of gear without serious health effects tend to also be a bit resistant to lower doses of other drugs. Some people’s bodies are just like Sherman tanks in that regard.
First time I used, thought it was bunk. I was so afraid to touch it, I was like maybe I'll try 100-150mg/week, 4 weeks into tren I already broke the 300-400mg threshold. 0 sides, 0 issues with blood markers, 0 RHR increase.

However my caloric intake and physique did look different so tren did work. But I'd imagine someone else in my place would have had a very significant transformation on that dose.

I also tank my e2 on only 450mg mast on 750mg test e. Which is super weird for me. I have naturally low prolactin so now I'm forced to use tren to get my prolactin within range. It's my custom cycle support.


"The tren as cycle support was a joke, but I rly do like the fact it bring my prolactin to within the reference range"
 
First time I used, thought it was bunk. I was so afraid to touch it, I was like maybe I'll try 100-150mg/week, 4 weeks into tren I already broke the 300-400mg threshold. 0 sides, 0 issues with blood markers, 0 RHR increase.

However my caloric intake and physique did look different so tren did work. But I'd imagine someone else in my place would have had a very significant transformation on that dose.

I also tank my e2 on only 450mg mast on 750mg test e. Which is super weird for me. I have naturally low prolactin so now I'm forced to use tren to get my prolactin within range. It's my custom cycle support.


"The tren as cycle support was a joke, but I rly do like the fact it bring my prolactin to within the reference range"
Very interesting. I ran higher dose Tren in my 20’s and tolerated it fine. No sides at all. I’m just more ginger with it at my old age. My superstition with Tren is that tolerating it well is a trap(for me). I’ll run it higher for longer and feel fine and then one day my labs will be garbage and my BP will be 180/100. Hasn’t happened yet tho.
 
Very interesting. I ran higher dose Tren in my 20’s and tolerated it fine. No sides at all. I’m just more ginger with it at my old age.
No joke, after introducing 600mg tren, my LDL trended below reference and my eGFR actually went above my natural baseline. I only added astralagus and didn't use any statins just normal lipid supplements like citrus bergmot/red rice yeast.
 
Clinical studies in people with obesity and type 2 diabetes have shown that bimagrumab can simultaneously build muscle and reduce fat, lowering A1C and fasting glucose without changes in diet or calorie intake.
....
In a nutshell, bimagrumab aims to improves body composition and metabolic health without the appetite suppression or GI issues typical of GLP-1 drugs.
I read about it before, but wasn't aware it is already in Stage 2 trials.
Shouldn't that mean, the Chinese are already able to manufacture it by now?
They don't have to do it for me, but for all the fat soccer moms.
 
Very reliable I'd say, have bought other products from them before no issue and they provide 3rd party testing. Might try another source though in the future just so I can definitively say for sure
Well, I understand the itch to get it again when you see people who claim success when you haven’t. I guess it all depends if you consider the financial risk and also the chances it will be effective.

Some people need higher doses (2.4–4.5 mg weekly) of cagrilintide for it to “kick in.”.

Below 1.2 mg it can feel like water, the amylin pathway isn’t fully engaged.

In trials, about 15–25 % were non-responders at low doses, and roughly half of them responded after escalation to 2.4–4.5 mg.

Those still unaffected at 4.5 mg are likely true amylin-pathway non-responders, and pushing the dose higher offers no added benefit.

Doses up to 4.5 mg weekly were clinically safe, with mostly mild GI effects.
 
Well, I understand the itch to get it again when you see people who claim success when you haven’t. I guess it all depends if you consider the financial risk and also the chances it will be effective.

Some people need higher doses (2.4–4.5 mg weekly) of cagrilintide for it to “kick in.”.

Below 1.2 mg it can feel like water, the amylin pathway isn’t fully engaged.

In trials, about 15–25 % were non-responders at low doses, and roughly half of them responded after escalation to 2.4–4.5 mg.

Those still unaffected at 4.5 mg are likely true amylin-pathway non-responders, and pushing the dose higher offers no added benefit.

Doses up to 4.5 mg weekly were clinically safe, with mostly mild GI effects.
Great thanks for this detailed insight! Looks like I gave up too early at 1.25mg and there's still hope
 
I started way low out of caution, 500mcg, but I think I called it quits at 3mg.
Yeah, maybe from a cost effectiveness perspective, if ur starting ur dose at 2.4-3mg, eventually you'll be using a vial in less than 2 weeks. If Semaglutide works for u, then you'd be paying around $95 for a 20mg kit and will last u very long on the 2.4mg dose of sema. (idk sema doses but I think 2.4mg is around the clinical trial max dose, I think they did another phase trying 2.8-3mg)
 
The largest contributions to GLP-1s making you lose weight is delayed gastric emptying and early satiety. Some also boost metab. The thing about appetite (desire to eat), is that it somewhat always returns if you had a healthy appetite before meds. Like, even people who do away with their stomachs with bariatric surgery and lose Ghrelin producing cells tanking their appetite suffer from a return to normal levels of hunger a few years after.

When you start losing weight, the body starts adapting immediately. Chronic caloric deficit causes the weight loss stabilizers in the hypothalamus and in other parts of the body to start doing things to defend body weight. It starts upregulating ghrelin synthesis over time, Necessitating higher doses of meds..
The hypothalamic–pituitary–gut axis has been and is being extensively studied to better understand the issues with appetite and appetite regulation.
When the code is properly and permanently cracked, we might see better meds for regulating appetite/hunger.
For now the battle is to keep attacking Ghrelin levels and NPY/AgRp Neurons.

GLP-1s directly prevent the firing of NPY/AgRP neurons causing increased satiety and reducing food seeking behaviour (food noise and appetite). This indirectly drops ghrelin levels. Glp-1s also targets neural stimulation and inhibits Ghrelin release.
GIP on the other hand actually increases appetite Which is why Tirz and Reta feel better than sema. However, GIP when combined with GLP-1RAs hits the NPY/AgRp neurons harder boosting satiety e.t.c with less feelings of bloat or nausea like Sema does.
The glucagon in Reta increases energy expenditure and stimulate thermogenesis.

The reason for all the bullshit I just typed is to explain that once the body keeps sensing a calorific deficit, and deems it as getting worse, it starts upregulating ghrelin production, meaning less stimulus is needed to secrete ghrelin and more inhibition is needed to suppress the firing of NPY/AgRP neurons. Meaning you will need to take more meds to produce similar levels of inhibition.
Also the receptors for GLP1s can get temporarily lost from cell surfaces blunting their actions. Considering that these are primarily neuronal actions, there can be a drop downstream signaling so even though the Meds are hitting the receptors, the nerves just aren't firing enough

When GLP receptors are exposed to continuous high doses of Meds, they undergo internalization. They are either recycled or degraded. This are natural actions designed to maintain balance.
What is causing reduction in the activity of the meds is less of receptor overwork or saturation, but rather due to the brain adapting and upregulating counter measured. Weight loss plateaus happen all the time because of the body's predilection to achieve weight stability. It's not receptor loss or receptor overwork.
So at some point, adding higher dose of meds won't work.

When people take break from Glp-1s, my suspicion is that the increase calorie intake causes the body to taper it's upregulation of food seeking behavior /appetite. It's not really 'receptor refresh'
A better way to tackle this is to add another class of meds to your schedule. If you are on reta, you can step up your reta dose, or add Cagrilintide for example.

Excuse the long post.. Had some free time.
 
Yeah, maybe from a cost effectiveness perspective, if ur starting ur dose at 2.4-3mg, eventually you'll be using a vial in less than 2 weeks. If Semaglutide works for u, then you'd be paying around $95 for a 20mg kit and will last u very long on the 2.4mg dose of sema. (idk sema doses but I think 2.4mg is around the clinical trial max dose, I think they did another phase trying 2.8-3mg)
7.2 mg... STEP-UP Trials
 
I didn't feel a single thing from cagri at any dose either. Multiple sources.
Cagri alone doesn't work that well.. I think in the clinical trial, 2.4 cagri was worse than 2.4 Sema. The max dose tested for safety (at 68 weeks) was 4.5mg, and for some reason they chose to compare it to Liraglutide. Their goal was to prove Cagri+Sema is what bangs!! So I would say Try Cagri + sema
 
Last edited:
Cagri alone doesn't work that well.. lol. Even the clinical trials were in excess or 4.2mg. Cagri+Sema is what bangs!!
Yeah, from an outsider's perspective seeing cagri only used with sema and not tirz.

Nvm I just realized Tirz is made by Eli lilly and Sema/Cagri/Reta are Novo Nordisk. So I guess novo wouldn't allow for those trials anyways
 
Yeah, from an outsider's perspective seeing cagri only used with sema and not tirz.

Nvm I just realized Tirz is made by Eli lilly and Sema/Cagri/Reta are Novo Nordisk. So I guess novo wouldn't allow for those trials anyways
There is also a Tirz+ Cagri study in Obese rats. I guess were not too far from human studies... maybe 5-10 yrs depending on greed
 
There is also a Tirz+ Cagri study in Obese rats. I guess were not too far from human studies... maybe 5-10 yrs depending on greed
Seems like Novo is choking hard, trying to make a peptide called Amycretin, basically Sema + Cagri. Seems very inferior to the other GLP-1’s tho seeing the efficacy of cagri.
 
Back
Top